Market Value4,398,640,000
Total Holdings71
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OSH / Oak Street Health Inc
PAYX / Paychex, Inc.
NVTA / Invitae Corporation
SLGC / Standard BioTools Inc.
TCRR / Tcr2 Therapeutics Inc
BVS / Bioventus Inc.
ONEM / 1life Healthcare Inc
ZGNX / Zogenix Inc
IMGN / ImmunoGen, Inc.
LFST / LifeStance Health Group, Inc.
GMXAY / Genmab A/S
/ ONCOLOGY INSTITUTE INC/THE
CABA / Cabaletta Bio, Inc.
EPZM / Epizyme Inc
HOOK / HOOKIPA Pharma Inc.
UNH / UnitedHealth Group Incorporated
BEAM / Beam Therapeutics Inc.
CLDX / Celldex Therapeutics, Inc.
YMTX / Yumanity Therapeutics Inc
LVTX / LAVA Therapeutics N.V.
TCDA / Tricida Inc
RGNX / REGENXBIO Inc.
TRDA / Entrada Therapeutics, Inc.
AMED / Amedisys, Inc.
NLTX / Neoleukin Therapeutics, Inc.
DYNS / Dynamics Special Purpose Corp Class A
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
NVRO / Nevro Corp.
PROF / Profound Medical Corp.
ZYME / Zymeworks Inc.
OVID / Ovid Therapeutics Inc.
IMTX / Immatics N.V.
NGM / NGM Biopharmaceuticals, Inc.
STVN / Stevanato Group S.p.A.
ICUI / ICU Medical, Inc.
SYRS / Syros Pharmaceuticals, Inc.
SKIN / The Beauty Health Company
VERV / Verve Therapeutics, Inc.
LIVN / LivaNova PLC
XERS / Xeris Biopharma Holdings, Inc.
AKRO / Akero Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
AYLA / Ayala Pharmaceuticals Inc
CTSO / Cytosorbents Corporation
SGEN / Seagen Inc
RCEL / AVITA Medical, Inc.
PRTA / Prothena Corporation plc
ELV / Elevance Health, Inc.
STOK / Stoke Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
NUVB / Nuvation Bio Inc.
ALXO / ALX Oncology Holdings Inc.
MDVL / MedAvail Holdings, Inc.
PLRX / Pliant Therapeutics, Inc.
ISEE / IVERIC bio Inc
TKNO / Alpha Teknova, Inc.
CNC / Centene Corporation
IGMS / IGM Biosciences, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
JAZZ / Jazz Pharmaceuticals plc
KYMR / Kymera Therapeutics, Inc.
STXS / Stereotaxis, Inc.
SONX / Sonendo, Inc.
RPTX / Repare Therapeutics Inc.
NRIX / Nurix Therapeutics, Inc.
ANNX / Annexon, Inc.
STTK / Shattuck Labs, Inc.
KRYS / Krystal Biotech, Inc.
GRTSQ / Gritstone bio, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
REPL / Replimune Group, Inc.
ALLK / Allakos Inc.
BCEL / Atreca, Inc.
IVVD / Invivyd, Inc.
LSAQ / LifeSci Acquisition II Corp
ATRA / Atara Biotherapeutics, Inc.
ALVR / AlloVir, Inc.
ABSI / Absci Corporation
FATE / Fate Therapeutics, Inc.
AUGX / Augmedix, Inc.
ADCT / ADC Therapeutics SA